About T&R Biofab
T&R Biofab is a publicly listed company based in Siheung-si (South Korea) founded in 2013. 3D printing technology for regenerating living tissues is provided. The company has 97 employees. T&R Biofab has completed 1 acquisition, including Bliss Pack. Its chief executive, as recorded, is Yunwonsu. Its website tnrbiofab.com draws about 10 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and 3D Bioprinting.
Company details
TR Biofab was founded in 2013 as a provider in the biotechnology sector. 3D printing technology is utilized for the regeneration of living tissues, with operations focused on medical devices and bio-surgical solutions. Offerings include ECM-based biosurgical products, 3D bioprinted organoids, and cell therapies based on induced pluripotent stem cells. The company operates through its domain tnrbiofab.com, led by CEO Yunwonsu.
- Headquarters Siheung-si, South Korea
- Employees 97
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website tnrbiofab.com
- Legal Name T&R Biofab Co., Ltd
- Annual Revenue$18.67 M (USD)453.32as on Dec 31, 2025
- Net Profit-$22.12 M (USD)-316.1as on Dec 31, 2025
- EBITDA-$2.51 M (USD)66.64as on Dec 31, 2025
- Employee Count97
- Investments & Acquisitions
People of T&R Biofab
1 people are tracked at T&R Biofab (1 in leadership); the tracked headcount is 97.
| Name | Role | Group |
|---|---|---|
Yunwonsu | CEO | Leadership |
Complete people profiles for T&R Biofab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of T&R Biofab
T&R Biofab is a publicly listed company on the KRX with ticker symbol 246710 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 Nov 2018
- Listed onKRX: 246710
- Listed entityT&R Biofab Co., Ltd
- Exchange sectorHealth technology
- ISINKR7246710008
- Share price2,050.00 KRW · 2026-10-14
- Market capitalisation97,712,235,260.00 KRW
- EPS (diluted, trailing year)-738.41 KRW
- Volume (last session)105,934
Financials of T&R Biofab
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 26.97B KRW | -31.95B KRW | -3.63B KRW |
| 2024 | 4.87B KRW | -7.68B KRW | -10.90B KRW |
| 2023 | 5.20B KRW | -13.42B KRW | -10.70B KRW |
| 2022 | 5.75B KRW | -10.34B KRW | -10.78B KRW |
| 2021 | 3.23B KRW | -70.07B KRW | -8.98B KRW |
Detailed financial statements for T&R Biofab
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by T&R Biofab
T&R Biofab has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Bliss Pack.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Packaging products are manufactured and cosmetics development services are provided. | blisspack.com | 2002 | Dec 2024 | •••• |
Complete acquisition details for TR Biofab
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of T&R Biofab
3 dated milestones of T&R Biofab across 11 years, from founding to its latest funding, stage changes and deals.
- Founded T&R Biofab is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Bliss Pack.
Web traffic of T&R Biofab
The website of T&R Biofab (tnrbiofab.com) receives about 10.4K visits a month.
- Monthly visits10.4K
▼ 13.1% vs previous month
Websites whose visitors overlap most with T&R Biofab. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
medicaltimes.com | medicaltimes.com | 100% | #99,676 | – | |
| medigatenews.com | 100% | #143,063 | View details | ||
| medicopharma.co.kr | 70% | #596,014 | View details | ||
littlebproject.com | littlebproject.com | 39% | #328,547 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about T&R Biofab
Complete news archive for TR Biofab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about T&R Biofab
T&R Biofab was founded in 2013.
T&R Biofab is headquartered in Siheung-si, South Korea. It is registered at Siheung-si, Gyeonggi-do, South Korea.
Yunwonsu is the CEO of T&R Biofab, as recorded in our data.
T&R Biofab has 97 employees.
Annual revenue of T&R Biofab is $18.67M as on Dec 31, 2025.
TR Biofab was founded in 2013 as a provider in the biotechnology sector. 3D printing technology is utilized for the regeneration of living tissues, with operations focused on medical devices and bio-surgical solutions. Offerings include ECM-based biosurgical products, 3D bioprinted organoids, and cell therapies based on induced pluripotent stem cells. The company operates through its domain tnrbiofab.com, led by CEO Yunwonsu.
Yes, T&R Biofab is publicly traded on KRX under the ticker symbol 246710.
T&R Biofab has made 1 acquisition, including Bliss Pack.